SI - NYSE
Shoulder Innovations, Inc.
$13.83
-1.2%Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
At a Glance
Live SnapshotShoulder Innovations, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Neutral working capital impact. Changes in current assets and liabilities balanced out.
Shoulder Innovations, Inc. Cash Flow Statement
SI • NYSE
| Shoulder Innovations, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
OPERATING ACTIVITIES | |||
-40.4M | -15.6M | -12.7M | |
3.2M | 2.2M | 1.6M | |
996K | 754K | 451K | |
7.5M | -437K | 2.2M | |
0.0 | -1M | -4.8M | |
-28.6M | -14.1M | -13.1M | |
INVESTING ACTIVITIES | |||
-7.4M | -4M | -2.7M | |
-119.5M | -5.3M | -29.3M | |
31.3M | 23.3M | 3M | |
-95.6M | (14M) | -29M | |
FINANCING ACTIVITIES | |||
0.0 | 66K | 0.0 | |
0.0 | 0.0 | 10M | |
145M | 0.0 | -149K | |
145M | 66K | 44.7M | |
CASH FLOW SUMMARY | |||
20.7M | -113K | 2.6M | |
6.1M | 6.2M | 3.6M | |
26.9M | 6.1M | 6.2M | |
-36M | -18.2M | -15.9M |
SEC Filings
SI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 13, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 14, 2026 | April 13, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 10, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 10, 2026 | March 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 03, 2025 | December 03, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your SI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.